Sessions addressing supportive care needs for patients with cancer on early phase clinical trials appeared feasible and acceptable in a prospective study.

Jonathan Kimmelman, PhD, has published multiple research papers and gotten into an inordinate number of debates about the clinical value of phase 1 trials.“I’ve argued for a long time that for phase 1 ...

Because RNAs are so central to our biology, they are also drivers of a wide array of diseases. Defects in how RNA is produced and processed can lead to cancer, degenerative diseases, metabolic ...

With trial costs rising over the past decade and concerns they’ll keep climbing, companies are seeking ways to manage ...

Schrödinger’s stock surged after the FDA's initiative to phase out animal testing, benefiting its computational drug ...

The FDA laid out a three-year roadmap to phase out animal toxicity testing in drug research. In addition to organoids and lab ...

A new kind of vaccine is changing how people think about preventing breast cancer. Not just any breast cancer—this one ...

From a tiny sample of tissue no larger than a grain of sand, scientists have come within reach of a goal once thought unattainable: building a complete functional wiring diagram of a portion of the ...

Gastrointestinal (GI) cancers represent a significant global health burden with complex biological behaviors and ...

IGC Pharma (IGC) announced the expansion of its ongoing Phase 2 CALMA clinical trial with the addition of Butler Hospital’s Memory and Aging ...

As the Trump administration makes cuts to federal health agencies, some Alzheimer's experts are worried about the impact on ...

The Trump administration this week decimated HIV prevention programs across government health agencies after terminating ...